EP2913335 - ANTI-TUMOR BIVALENT PLATINUM COMPLEX AND PREPARATION METHOD FOR COMPLEX AND LIGAND OF COMPLEX [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.02.2018 Database last updated on 15.06.2024 | |
Former | The patent has been granted Status updated on 24.02.2017 | ||
Former | Grant of patent is intended Status updated on 03.11.2016 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Southeast University No. 2 Sipailou, Xuanwu Nanjing Jiangsu 210096 / CN | [2015/36] | Inventor(s) | 01 /
GOU, Shaohua No.2 Sipailou Xuanwu Nanjing Jiangsu 210096 / CN | [2015/36] | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [N/P] |
Former [2015/36] | ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | Application number, filing date | 13851191.0 | 29.08.2013 | [2015/36] | WO2013CN82513 | Priority number, date | CN201210422936 | 29.10.2012 Original published format: CN201210422936 | [2015/36] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014067336 | Date: | 08.05.2014 | Language: | ZH | [2014/19] | Type: | A1 Application with search report | No.: | EP2913335 | Date: | 02.09.2015 | Language: | EN | [2015/36] | Type: | B1 Patent specification | No.: | EP2913335 | Date: | 29.03.2017 | Language: | EN | [2017/13] | Search report(s) | International search report - published on: | CN | 08.05.2014 | (Supplementary) European search report - dispatched on: | EP | 21.03.2016 | Classification | IPC: | C07F15/00, A61K31/282, A61P35/00 | [2015/36] | CPC: |
C07F15/0066 (EP,US);
C07F15/0093 (US);
A61K31/282 (US);
A61P35/00 (EP);
C07F15/00 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/36] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | BIVALENTER ANTI-TUMOR-PLATINKOMPLEX UND HERSTELLUNGSVERFAHREN FÜR DEN KOMPLEX UND LIGAND DES KOMPLEXES | [2015/36] | English: | ANTI-TUMOR BIVALENT PLATINUM COMPLEX AND PREPARATION METHOD FOR COMPLEX AND LIGAND OF COMPLEX | [2015/36] | French: | COMPLEXE DU PLATINE BIVALENT ANTITUMORAL ET PROCÉDÉ DE PRÉPARATION D'UN COMPLEXE ET D'UN LIGAND DE COMPLEXE | [2015/36] | Entry into regional phase | 11.05.2015 | Translation filed | 11.05.2015 | National basic fee paid | 11.05.2015 | Search fee paid | 11.05.2015 | Designation fee(s) paid | 11.05.2015 | Examination fee paid | Examination procedure | 11.05.2015 | Examination requested [2015/36] | 01.09.2016 | Amendment by applicant (claims and/or description) | 04.11.2016 | Communication of intention to grant the patent | 20.02.2017 | Fee for grant paid | 20.02.2017 | Fee for publishing/printing paid | 20.02.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.11.2016 | Opposition(s) | 03.01.2018 | No opposition filed within time limit [2018/10] | Fees paid | Renewal fee | 25.08.2015 | Renewal fee patent year 03 | 28.07.2016 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 29.08.2013 | AL | 29.03.2017 | AT | 29.03.2017 | CY | 29.03.2017 | CZ | 29.03.2017 | DK | 29.03.2017 | EE | 29.03.2017 | FI | 29.03.2017 | HR | 29.03.2017 | LT | 29.03.2017 | LV | 29.03.2017 | MC | 29.03.2017 | MK | 29.03.2017 | NL | 29.03.2017 | PL | 29.03.2017 | PT | 29.03.2017 | RO | 29.03.2017 | RS | 29.03.2017 | SE | 29.03.2017 | SI | 29.03.2017 | SK | 29.03.2017 | SM | 29.03.2017 | TR | 29.03.2017 | BG | 29.06.2017 | NO | 29.06.2017 | GR | 30.06.2017 | IS | 29.07.2017 | IE | 29.08.2017 | LU | 29.08.2017 | MT | 29.08.2017 | BE | 31.08.2017 | CH | 31.08.2017 | LI | 31.08.2017 | [2020/34] |
Former [2020/28] | HU | 29.08.2013 | |
AT | 29.03.2017 | ||
CY | 29.03.2017 | ||
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
MK | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
PT | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
TR | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2020/15] | HU | 29.08.2013 | |
AT | 29.03.2017 | ||
CY | 29.03.2017 | ||
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
MK | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
TR | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2019/52] | HU | 29.08.2013 | |
AT | 29.03.2017 | ||
CY | 29.03.2017 | ||
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
MK | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2019/47] | HU | 29.08.2013 | |
AT | 29.03.2017 | ||
CY | 29.03.2017 | ||
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2019/31] | HU | 29.08.2013 | |
AT | 29.03.2017 | ||
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/43] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
MT | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/39] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
BE | 31.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/34] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
IE | 29.08.2017 | ||
LU | 29.08.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/25] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SI | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/21] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
CH | 31.08.2017 | ||
LI | 31.08.2017 | ||
Former [2018/18] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
MC | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
Former [2018/09] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
DK | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
Former [2017/51] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
SM | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
Former [2017/50] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
PL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
Former [2017/49] | AT | 29.03.2017 | |
CZ | 29.03.2017 | ||
EE | 29.03.2017 | ||
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
RO | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
SK | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
IS | 29.07.2017 | ||
Former [2017/48] | CZ | 29.03.2017 | |
FI | 29.03.2017 | ||
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | ||
Former [2017/41] | FI | 29.03.2017 | |
HR | 29.03.2017 | ||
LT | 29.03.2017 | ||
LV | 29.03.2017 | ||
NL | 29.03.2017 | ||
RS | 29.03.2017 | ||
SE | 29.03.2017 | ||
BG | 29.06.2017 | ||
NO | 29.06.2017 | ||
GR | 30.06.2017 | Documents cited: | Search | [A]WO2004099224 (UNIV REGENSBURG [DE], et al) [A] 1-5 * Carboplatin and its use against tumorous disease: top of page 4 and 2nd paragraph * * Process of Pt-complex synthesis: figures 1 and 2 in combination as well as figures 4 and 5 in combination * * Diammine[3-hydroxy-1,1-cyclobutanedicarboxylato(2-)-platinum (compound 90) [(1R,2R)-1,2-cyclohexanediamine][3-hydroxy-1,1-cyclobutanedicarboxylato-platinum (compound 94) * * Use of Pt-amino complexes in treatment of tumorous diseases: claim 17 *; | [A]CN101967163 (KUNMING INST OF PRECIOUS METAL, et al) [A] 1-5 * Process of forming cis-Pt diamino complexes by reaction of cis-diamino-dihalo Pt complexes with diargento-cyclobutyl-1,1-dicarboxylate: 2nd reaction scheme on page 5 *; | [XP]CN102924528 (UNIV SOUTHEAST) [XP] 1-5 * Diammine[3-oxo-1,1-cyclobutanedicarboxylato(2-)-platinum; [(1R,2R)-1,2-cyclohexanediamine][3-oxo-1,1-cyclobutanedicarboxylato-platinum: see page 2, compounds 1-2 ** Process to make these complexes by reaction of the cis-diamino-dihalo Pt complex with disodium or dipotassium salt of 3-oxo-1,1-cyclobutanedicarboxylic acid: see pages 3, 5, 8. * | International search | [A]WO2004099224 (UNIV REGENSBURG [DE], et al); | [A]CN101967163 (KUNMING INST OF PRECIOUS METAL, et al); | [A]CN102079761 (KUNMING INST PRECIOUS METALS, et al); | [A]CN102234295 (UNIV SOUTHEAST); | [XP]CN102924528 (UNIV SOUTHEAST); | [A] - BERNHARDT, G. ET AL., "Carboplatin derivatives with superior antitumor activity compared to the parent compound.", INORGANICACHIMICAACTA., (20040820), vol. 357, no. 15, pages 4452 - 4466, XP004652322 DOI: http://dx.doi.org/10.1016/j.ica.2004.03.060 | [A] - LIU, WEIPING ET AL., "A Novel Water-Soluble Heptaplatin Analogue with Improved Antitumor Activity and Reduced Toxicity.", INORGANIC CHEMISTRY, (20110520), vol. 50, no. 12, pages 5324 - 5326, XP055245878 DOI: http://dx.doi.org/10.1021/ic200436u | [A] - ALLAN, R.D. ET AL., "Synthesis and Activity of a Potent N-Methyl-D- aspartic Acid Agonist, trans-1-Aminocyclobutane-1,3-dicarboxylic Acid, and Related Phosphonic and Carboxylic Acids.", J. MED. CHEM., (19901231), vol. 33, no. 10, pages 2905 - 2915, XP002520828 DOI: http://dx.doi.org/10.1021/jm00172a036 | by applicant | - J. FLUORINE CHEM., (2010), vol. 131, page 221 | - J. ORG. CHEM., (1988), vol. 53, page 3841 | - J. MED. CHEM., (1990), vol. 33, page 1905 | - JOURNAL OF BEIJING UNIVERSITY OF TECHNOLOGY, (1998), vol. 24, page 97 | - TOXICOLOGY & APPLIED PHARMACOLOGY,, (1973), vol. 25, page 230 | - NORTHWEST PHARMACEUTICAL JOURNAL, (2001), vol. 16, no. 2, page 67 | - JOURNAL OF ZHEJIANG ACADEMY OF MEDICAL SCIENCES, (1993), vol. 15, page 33 |